{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:08:27Z","timestamp":1778882907381,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["202240149"],"award-info":[{"award-number":["202240149"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["JYLJ202209"],"award-info":[{"award-number":["JYLJ202209"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ijcha.2024.101353","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T04:58:49Z","timestamp":1707195529000},"page":"101353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The impacts of prophylactic anticoagulation therapy during hospitalization on long-term cardiovascular outcomes in high-risk COVID-19 patients amid the omicron wave of the pandemic"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0999-864X","authenticated-orcid":false,"given":"Jun","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ijcha.2024.101353_b0005","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1515\/cclm-2020-0188","article-title":"Prominent changes in blood coagulation of patients with SARS-CoV-2 infection","volume":"58","author":"Han","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"issue":"23","key":"10.1016\/j.ijcha.2024.101353_b0010","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/CIRCULATIONAHA.120.047164","article-title":"The Variety of Cardiovascular Presentations of COVID-19","volume":"141","author":"Fried","year":"2020","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ijcha.2024.101353_b0015","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/rth2.12439","article-title":"Risk of venous thromboembolism in patients with COVID-19: a systematic review and meta-analysis","volume":"4","author":"Nopp","year":"2020","journal-title":"Res Pract Thromb Haemost."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101353_b0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"23","key":"10.1016\/j.ijcha.2024.101353_b0025","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcha.2024.101353_b0030","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijcha.2024.101353_b0035","doi-asserted-by":"crossref","unstructured":"Cuker A, Tseng EK, Nieuwlaat R, etal. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients. Blood Adv. 2021;5(20):3951-3959. Blood Adv. 2023;7(5):811. 10.1182\/bloodadvances.2022008060.","DOI":"10.1182\/bloodadvances.2022008060"},{"issue":"2","key":"10.1016\/j.ijcha.2024.101353_b0040","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ijcha.2024.101353_b0045","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M20-2003","article-title":"Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study","volume":"173","author":"Wichmann","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"18","key":"10.1016\/j.ijcha.2024.101353_b0050","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.jacc.2020.08.070","article-title":"Registry of arterial and venous thromboembolic complications in patients with COVID-19","volume":"76","author":"Piazza","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2024.101353_b0055","article-title":"Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study","volume":"372","author":"Rentsch","year":"2021","journal-title":"BMJ"},{"issue":"16","key":"10.1016\/j.ijcha.2024.101353_b0060","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jacc.2020.08.041","article-title":"Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19","volume":"76","author":"Nadkarni","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcha.2024.101353_b0065","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/bloodadvances.2020003763","article-title":"American society of hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19","volume":"5","author":"Cuker","year":"2021","journal-title":"Blood Adv."},{"issue":"9","key":"10.1016\/j.ijcha.2024.101353_b0070","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jacc.2021.12.023","article-title":"Anticoagulation in patients with COVID-19: JACC review topic of the week","volume":"79","author":"Farkouh","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2024.101353_b0075","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.2147\/IDR.S410374","article-title":"Clinical outcomes of anticoagulant therapy in COVID-19 patients with pre-existing cardiovascular diseases: a systematic review","volume":"16","author":"Alhawiti","year":"2023","journal-title":"Infect Drug Resist."},{"key":"10.1016\/j.ijcha.2024.101353_b0080","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijcard.2019.11.087","article-title":"Association between long-term prescription of metformin and the progression of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and hypertension","volume":"306","author":"Gu","year":"2020","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcha.2024.101353_b0085","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00392-021-01939-3","article-title":"Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities","volume":"111","author":"Rieder","year":"2022","journal-title":"Clin. Res. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101353_b0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/bjh.17787","article-title":"Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK - a multicentre observational study","volume":"196","author":"Arachchillage","year":"2022","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.ijcha.2024.101353_b0095","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1093\/gerona\/glaa146","article-title":"Italian National Institute of Health COVID-19 Mortality Group. Clinical Characteristics of Hospitalized Individuals Dying With COVID-19 by Age Group in Italy","volume":"75","author":"Palmieri","year":"2020","journal-title":"J. Gerontol. Seri. A, Biol. Sci. Med. Sci."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101353_b0100","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/eurheartj\/ehaa190","article-title":"Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin","volume":"42","author":"Hu","year":"2021","journal-title":"Eur. Heart J."},{"issue":"22","key":"10.1016\/j.ijcha.2024.101353_b0105","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1093\/eurheartj\/ehaa253","article-title":"Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19","volume":"41","author":"Hua","year":"2020","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ijcha.2024.101353_b0110","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2020.05.001","article-title":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19","volume":"76","author":"Paranjpe","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcha.2024.101353_b0115","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"Levi","year":"2020","journal-title":"Lancet Haematol."},{"issue":"8","key":"10.1016\/j.ijcha.2024.101353_b0120","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(22)00175-2","article-title":"OVID investigators. enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial","volume":"9","author":"Barco","year":"2022","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.ijcha.2024.101353_b0125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.thromres.2022.10.021","article-title":"OVID investigators. Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial","volume":"221","author":"Voci","year":"2023","journal-title":"Thromb. Res."},{"issue":"8","key":"10.1016\/j.ijcha.2024.101353_b0130","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2352-3026(22)00173-9","article-title":"ETHIC investigators. Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial","volume":"9","author":"Cools","year":"2022","journal-title":"Lancet Haematol."},{"issue":"10319","key":"10.1016\/j.ijcha.2024.101353_b0135","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(21)02392-8","article-title":"MICHELLE investigators. rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial","volume":"399","author":"Ramacciotti","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijcha.2024.101353_b0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","volume":"94","author":"Yang","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"19","key":"10.1016\/j.ijcha.2024.101353_b0145","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/eurheartj\/ehaa388","article-title":"Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy","volume":"41","author":"Inciardi","year":"2020","journal-title":"Eur. Heart J."},{"issue":"7821","key":"10.1016\/j.ijcha.2024.101353_b0150","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.ijcha.2024.101353_b0155","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S2213-8587(20)30271-0","article-title":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study","volume":"8","author":"Holman","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"10.1016\/j.ijcha.2024.101353_b0160","first-page":"252","article-title":"Investigadores del estudio EMERG-AF. Sex-related differences in benefits of anticoagulation therapy in elderly patients with atrial fibrillation: a subanalysis of the EMERG-AF study","volume":"35","author":"Varona","year":"2023","journal-title":"Emergencias."},{"issue":"8","key":"10.1016\/j.ijcha.2024.101353_b0165","doi-asserted-by":"crossref","first-page":"e28992","DOI":"10.1002\/jmv.28992","article-title":"Effectiveness of oral antiviral agents on long-term cardiovascular risk in nonhospitalized patients with COVID-19: A multicenter matched cohort study","volume":"95","author":"Liu","year":"2023","journal-title":"J. Med. Virol."},{"issue":"9","key":"10.1016\/j.ijcha.2024.101353_b0170","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jacc.2022.12.006","article-title":"N3C Consortium. Impact of Vaccination on Major Adverse Cardiovascular Events in Patients With COVID-19 Infection","volume":"81","author":"Jiang","year":"2023","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906724000198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906724000198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:18:13Z","timestamp":1778879893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906724000198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":34,"alternative-id":["S2352906724000198"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2024.101353","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impacts of prophylactic anticoagulation therapy during hospitalization on long-term cardiovascular outcomes in high-risk COVID-19 patients amid the omicron wave of the pandemic","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2024.101353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101353"}}